Mitochondrial Transcription Factor A, an Endogenous Danger Signal, Promotes TNFα Release via RAGE- and TLR9-Responsive Plasmacytoid Dendritic Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Julian, Mark W ^a   Shao, Guohong ^a   VanGundy, Zachary C ^b   Papenfuss, Tracey L ^b   Crouser, Elliott D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ENDOTHELIN CONVERTING ENZYME; FLT3 LIGAND; HEPARIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOCHONDRIAL TRANSCRIPTION FACTOR A BOX 1; MITOCHONDRIAL TRANSCRIPTION FACTOR A BOX 2; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL EXPANSION; CELL INTERACTION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE RELEASE; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMACYTOID DENDRITIC CELL; PROTEIN CLEAVAGE; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SPLEEN CELL;

ANIMALS; CELL LINE; CPG ISLANDS; DENDRITIC CELLS; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; HMGB1 PROTEIN; HMGB2 PROTEIN; HUMANS; MALE; MICE; MITOCHONDRIAL PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; SIGNAL TRANSDUCTION; SPLEEN; TOLL-LIKE RECEPTOR 9; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881506336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072354     Document Type: Article

References (52)

1. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107. doi:10.1038/nature08780. PubMed: 20203610.
2. Julian MW, Shao G, Bao S, Knoell DL, Papenfuss TL, et al. (2012) Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J Immunol 189: 433-443. doi:10.4049/jimmunol.1101375. PubMed: 22675199.
3. Crouser ED, Shao G, Julian MW, Macre JE, Shadel GS, et al. (2009) Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med 37: 2000-2009. doi:10.1097/CCM.0b013e3181a001ae. PubMed: 19384205.
4. Galluzzi L, Kepp O, Kroemer G, (2012) Mitochondria: master regulators of danger signaling. Nat Rev Mol Cell Biol 13: 780-788. doi:10.1038/nrm3479. PubMed: 23175281.
5. Trinchieri G, (2010) Type I interferon: friend or foe? J Exp Med 207: 2053-2063. doi:10.1084/jem.20101664. PubMed: 20837696.
6. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, et al. (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. doi:10.1038/nature03464. PubMed: 15800576.
7. Villadangos JA, Young L, (2008) Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29: 352-361. doi:10.1016/j.immuni.2008.09.002. PubMed: 18799143.
8. McKenna K, Beignon AS, Bhardwaj N, (2005) Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol 79: 17-27. doi:10.1128/JVI.79.1.17-27.2005. PubMed: 15596797.
9. Scaffidi P, Misteli T, Bianchi ME, (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195. doi:10.1038/nature00858. PubMed: 12110890.
10. Nair JR, McGuire JJ, (2005) Submitochondrial localization of the mitochondrial isoforms of folylpolyglutamate synthetase in CCRF-CEM human T-lymphoblastic leukemia cells. Biochim Biophys Acta 1746: 38-44. doi:10.1016/j.bbamcr.2005.08.004. PubMed: 16169100.
11. Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, et al. (2000) Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res 60: 3239-3246. PubMed: 10866317.
12. Papenfuss TL, Kithcart AP, Powell ND, McClain MA, Gienapp IE, et al. (2007) Disease-modifying capability of murine Flt3-ligand DCs in experimental autoimmune encephalomyelitis. J Leukoc Biol 82: 1510-1518. doi:10.1189/jlb.0406257. PubMed: 17855499.
13. Engel A, Barton GM, (2010) Compartment-specific control of signaling from a DNA-sensing immune receptor. Sci Signal 150: e45. PubMed: 21119105.
14. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H, (2002) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62: 4805-4811. PubMed: 12183440.
15. Raoof M, Zhang Q, Itagaki K, Hauser CJ, (2010) Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1. J Trauma 68: 1328-1332. doi:10.1097/TA.0b013e3181dcd28d. PubMed: 20539176.
16. Rabiet MJ, Huet E, Boulay F, (2005) Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol 35: 2486-2495. doi:10.1002/eji.200526338. PubMed: 16025565.
17. Xu D, Young J, Song D, Esko JD, (2011) Heparin sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). J Biol Chem 286: 41736-41744. doi:10.1074/jbc.M111.299685. PubMed: 21990362.
18. Guiducci C, Ghirelli C, Marloie-Provost MA, Matray T, Coffman RL, et al. (2008) PI3K is critical for the nuclear translocation of IRF-7 and type I IFN production by human plasmacytoid predendritic cells in response to TLR activation. J Exp Med 205: 315-322. doi:10.1084/jem.20070763. PubMed: 18227218.
19. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, et al. (2008) Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 9: 1407-1401. doi:10.1038/ni.1669. PubMed: 18931679.
20. Bauer S, (2003) Toll-like receptor 9 processing: The key event in Toll-like receptor 9 activation? Immunol Lett 149: 85-87. PubMed: 23183093.
21. Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, et al. (2011) Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolones. J Immunol 186: 4794-4804. doi:10.4049/jimmunol.1000702. PubMed: 21398612.
22. Johnson LS, Dunn KW, Pytowski B, McGraw TE, (1993) Endosome acidification and receptor trafficking: bafilomycin A1 slows receptor externalization by a mechanism involving the receptor's internalization motif. Mol Biol Cell 4: 1251-1266. PubMed: 8167408.
23. Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, Bunnett NW, (2009) Endosomes: A legitimate platform for the signaling train. Proc Natl Acad Sci U S A 106: 17615-17622. doi:10.1073/pnas.0906541106. PubMed: 19822761.
24. Pelayo JC, Poole DP, Steinhoff M, Cottrell GS, Bunnett NW, (2011) Endothelin-converting enzyme-1 regulates trafficking and signaling of neurokinin 1 receptor in endosomes of myenteric neurons. J Physiol 589: 5213-5230. PubMed: 21878523.
25. Duan X, Yarmush D, Leeder A, Yarmush ML, Mitchell RN, (2008) Burn-induced immunosuppression: attenuated T cell signaling independent of IFN-γ- and nitric oxide-mediated pathways. J Leukoc Biol 83: 305-313. PubMed: 18024716.
26. Kajino K, Nakamura I, Bamba H, Sawai T, Ogasawara K, (2007) Involvement of IL-10 in exhaustion of myeloid dendritic cells and rescue by CD40 stimulation. Immunology 120: 28-37. PubMed: 17034426.
27. Cantaert T, Baeten D, Tak PP, van Baarsen LGM, (2010) Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance. Arthritis Res Ther 12: 219. doi:10.1186/ar3205. PubMed: 21062511.
28. Chaung WW, Wu R, Ji W, Wang P, (2012) Mitochondrial transcription factor A is a proinflammatory mediator in hemorrhagic shock. Int J Mol Med 30: 199-203. PubMed: 22469910.
29. West AP, Shadel GS, Ghosh S, (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11: 389-402. doi:10.1038/nri2975. PubMed: 21597473.
30. Rauvala H, Huttunen HJ, Fages C, Kaksonen M, Kinnunen T, et al. (2000) Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol 19: 377-387. doi:10.1016/S0945-053X(00)00084-6. PubMed: 10980414.
31. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, et al. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8: 487-496. doi:10.1038/nrg2148. PubMed: 17417641.
32. Parisi MA, Clayton DA, (1991) Similarity of human mitochondrial transcription factor 1 to high mobility group proteins. Science 252: 965-969. doi:10.1126/science.2035027. PubMed: 2035027.
33. Kang D, Kim SH, Hamasaki N, (2007) Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 7: 39-44. doi:10.1016/j.mito.2006.11.017. PubMed: 17280879.
34. Andersson U, Tracey KJ, (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29: 139-162. doi:10.1146/annurev-immunol-030409-101323. PubMed: 21219181.
35. Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, et al. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 107: 11942-11947. doi:10.1073/pnas.1003893107. PubMed: 20547845.
36. Wong TS, Rajagopalan S, Freund SM, Rutherford TJ, Andreeva A, et al. (2009) Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53. Nucleic Acids Res 37: 6765-6783. doi:10.1093/nar/gkp750. PubMed: 19755502.
37. Li Y, Berke IC, Modis Y, (2011) DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J 31: 919-931. doi:10.1038/emboj.2011.441. PubMed: 22258621.
38. Bamboat ZM, Ocuin LM, Balachandran VP, Obaid H, Plitas G, et al. (2010) Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. J Clin Invest 120: 559-569. doi:10.1172/JCI40008. PubMed: 20093775.
39. Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, et al. (2008) The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456: 658-662. doi:10.1038/nature07405. PubMed: 18820679.
40. Umekawa K, Hasegawa H, Tsutsumi Y, Sato K, Matsumura Y, et al. (2000) Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme. Jpn J Pharmacol 84: 7-15. doi:10.1254/jjp.84.7. PubMed: 11043447.
41. Matsumura Y, Kuro T, Kobayashi Y, Umekawa K, Ohashi N, et al. (2000) Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats. Jpn J Pharmacol 84: 16-24. doi:10.1254/jjp.84.16. PubMed: 11043448.
42. Blasius AL, Beutler B, (2010) Intracellular Toll-like receptors. Immunity 32: 305-315. doi:10.1016/j.immuni.2010.03.012. PubMed: 20346772.
43. Yao M, Liu X, Li D, Chen T, Cai Z, et al. (2009) Late endosome/lysosome-localized Rab7b suppresses TLR9-initiated proinflammatory cytokine and type I IFN production in macrophages. J Immunol 183: 1751-1758. doi:10.4049/jimmunol.0900249. PubMed: 19587007.
44. Christie JD, Wurfel MM, Feng R, O'Keefe GE, Bradfield J, et al. (2012) Genome wide association identifies PPFIA1 as a candidate gene for acute lung injury risk following major trauma. PLOS ONE 7: e28268. doi:10.1371/journal.pone.0028268. PubMed: 22295056.
45. Pillay J, Hietbrink F, Koenderman L, Leenen LP, (2007) The systemic inflammatory response induced by trauma is reflected by multiple phenotypes of blood neutrophils. Injury 38: 1365-1372. doi:10.1016/j.injury.2007.09.016. PubMed: 18061190.
46. Warren HS, Elson CM, Hayden DL, Schoenfeld DA, Cobb JP, et al. (2009) A genomic score prognostic of outcome in trauma patients. Mol Med 15: 220-227. PubMed: 19593405.
47. Noel G, Guo X, Wang Q, Schwemberger S, Byrum D, et al. (2007) Postburn monocytes are the major producers of TNF-alpha in the heterogeneous splenic macrophage population. Shock 27: 312-319. doi:10.1097/01.shk.0000239753.75088.5e. PubMed: 17304113.
48. Bao Y, Kim E, Bhosle S, Mehta H, Cho S, (2010) A role for spleen monocytes in post-ischemic brain inflammation and injury. J Neuroinflammation 7: 92. doi:10.1186/1742-2094-7-92. PubMed: 21159187.
49. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, et al. (2006) Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203: 1623-1628. doi:10.1084/jem.20052362. PubMed: 16785311.
50. Hoene V, Peiser M, Wanner R, (2006) Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19. J Leukoc Biol 80: 1328-1336. doi:10.1189/jlb.0106011. PubMed: 17000899.
51. Rao NV, Argyle B, Xu X, Reynolds PR, Walenga JM, et al. (2010) Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands. Am J Physiol Cell Physiol 299: C97-C110. doi:10.1152/ajpheart.01105.2009. PubMed: 20375277.
52. Gottmann U, Mueller-Falcke A, Schnuelle P, Birck R, Nickeleit V, et al. (2007) Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys. Transpl Int 20: 542-549. doi:10.1111/j.1432-2277.2007.00471.x. PubMed: 17355246.